Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Healthcare Biotechnology
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Trillium Therapeutics Inc.
Bullboard Posts
User Avatar Image
(2)
•••
Comment by Jovicaon May 19, 2010 2:13pm
338 Views
Post# 17114499

Bids drying up

Bids drying upLevel 2 Quote
Market Maker Shares Bid Price Ask Price Shares Market Maker
-- 40,000 0.365 0.370 45,000 --
-- 61,000 0.360 0.375 20,000 --
-- 74,000 0.355 0.380 43,500 --
-- 33,500 0.350 0.385 100,000 --
-- 36,500 0.340 0.390 63,000 --
-- 5,000 0.335 0.395 93,000 --
-- 32,500 0.330 0.400 184,000 --
-- 3,500 0.320 0.405 10,000 --
-- 55,000 0.315 0.410 30,000 --
-- 51,000 0.310 0.415 30,000 --
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities